Andrew A. Wahba, MD
- Cancer and Blood Disorders

Instructor, Department of Pediatrics, Division of Hematology-Oncology, Baylor College of Medicine
Office location:
Texas Medical Center
6701 Fannin Street
Houston, TX 77030
Get to know Andrew A. Wahba, MD
Dr. Andrew Wahba is a faculty member in the Division of Pediatric Hematology-Oncology at Baylor College of Medicine and Texas Children’s Hospital. He is also a member of the Center for Advanced Innate Cell Therapy (AICT).
Dr. Wahba provides clinical care for children with all types of pediatric solid tumors, including neuroblastoma, hepatoblastoma, Wilms tumor, bone and soft tissue sarcomas.
His research focuses on developing novel immunotherapeutic approaches for children with relapsed or refractory solid tumors.
He is board certified in Pediatrics by the American Board of Pediatrics.
Educacion
School | Education | Degree | Year |
---|---|---|---|
Baylor College of Medicine | Fellowship | Pediatric Hematology-Oncology | 2025 |
University of Texas Health Science Center | Residency | Pediatrics | 2022 |
Cairo University | Medical School | Doctor of Medicine | 2016 |
Organizaciones
Nombre de la Organizacion | Rol |
---|---|
American Academy of Pediatrics (AAP) | Member |
American Medical Association (AMA) | Member |
American Society of Clinical Oncology (ASCO) | Member |
American Society of Hematology (ASH) | Member |
American Society of Pediatric Hematology/Oncology (ASPHO) | Member |
Children's Oncology Group (COG) | Member |
Texas Medical Association (TMA) | Member |
Texas Pediatric Society | Member |
Board Certification
American Board of Pediatrics
Honors and awards
- 2023
-
Quality Award, Texas Children's Hospital, Cancer and Hematology Center
* Texas Children’s Hospital physicians’ licenses and credentials are reviewed prior to practicing at any of our facilities. Sections titled From the Doctor, Professional Organizations and Publications were provided by the physician’s office and were not verified by Texas Children’s Hospital.
Highlights
Area de investigacion:
Center for Advanced Innate Cell Therapy